Diabetes mellitus
Conditions
Interventions
investigational material(s)
Generic name etc : Actos combination drug
INN of investigational material :
Therapeutic category code : 396 Antidiabetic agents
Dosage and Administration for Investigation
Sponsors
Takeda Pharmaceutical Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Admission status: Outpatient 2.The subject who applies for participation in this study and is capable of giving written informed consent, reading informed consent form and other study-related documents, and understanding them, etc.
Exclusion criteria
Exclusion criteria: 1.The subject with serious cardiac disease, cerebrovascular disease, or serious pancreatic or hematological disease. 2.The subject is considered ineligible to participate in the study by the investigator or subinvestigator, etc.
Outcome results
None listed